NGVT News | Roxom Stocks

Invest Private Security Newsroom

Market Overview

Indices and commodities.

Bitcoin treasury preferreds.

The artificial intelligence theme.

Bitcoin Treasuries

Companies holding bitcoin.

Sectors, global markets and rates.

Popular Portfolios

13F filings, smart money.

Borrow USDT or USDC against your BTC without giving it up.

Switch your bitcoin-backed loan and pay less interest.

Borrow, invest, keep the spread.

Stock Dividends

Dividends from tokenized equities.

Company

Our leadership team, mission, and investors.

Vision, purpose, and architecture behind Roxom.

Terms, privacy, and disclosures.

Resources

Guides, FAQs & support.

Trading logic, platform rules, and fundamentals.

Connect, authenticate, and build with our API.

Current platform health and incidents.

Loading chart

Pay with

1 BTC

=

- USD

Loading market data...

Loading chart

Pay with

NG

Mkt Cap

$2.40B

Volume

118.96K

Next Earnings

November 4th

Loading chart

NG

NGVTIngevity Corporation

NGVT

Pay with—

Available Balance0.00

NG

Mkt Cap

$2.43B

Volume

118.96K

Next Earnings

November 4th

Chart Financials Earnings News About Insider Filings

Is NGVT Positioned for Further Adjusted EBITDA Improvement?Ingevity Corporation (NGVT) reported Q2 adjusted EBITDA of $115 million, up from $101 million year-over-year, driven by higher pricing, favorable product mix, and increased volumes. The company raised its 2026 adjusted EBITDA guidance to $380-$400 million and adjusted EPS outlook to $5-$5.45. NGVT stock has gained 26.3% over the past year and trades at a forward P/S multiple of 2.1, below the industry average of 2.45X.Zacks Investment Research · Oct 15, 2026

Here's Why You Should Hold Onto Ingevity Stock for NowIngevity Corporation (NGVT) shares have gained 33.9% over the past year driven by portfolio transformation, strategic divestitures, and disciplined capital allocation. The company is focusing on high-return markets and targeting $300 million in share repurchases through 2027. However, challenges include weakness in the APT business segment, macroeconomic uncertainties, and softer North American auto production forecasts. NGVT carries a Zacks Rank #3 (Hold) rating.Zacks Investment Research · Oct 7, 2026

NGVT Stock Rallies 31% in a Year: What's Driving the Upside?Ingevity Corporation (NGVT) shares have gained 30.6% over the past year, outperforming its industry. The company's portfolio optimization through divestitures and acquisitions, combined with improved cash flow generation and debt reduction to 2.5X leverage, has boosted investor confidence. NGVT is pursuing growth opportunities in PFAS filtration, biofuels applications, and capacity expansions while planning a $300 million share repurchase program through 2027.Zacks Investment Research · Sep 30, 2026

Global Activated Carbon Market Outlook 2026-2033: Water Treatment, Air Purification and Emissions Control Demand SurgesThe global activated carbon market is projected to grow from USD 6.1 billion in 2026 to USD 11.1 billion by 2033, with a CAGR of 8.90%. Growth is driven by stricter environmental regulations, increased water treatment infrastructure investment, and rising demand for air purification and industrial applications, particularly in Asia-Pacific.GlobeNewswire Inc. · Sep 24, 2026

Ingevity Shares Rise 19.2% YTD: Can the Stock Sustain the Rally?Ingevity Corporation (NGVT) shares have gained 19.2% year-to-date, outperforming its industry, driven by successful portfolio optimization, divestitures, and increased demand for hybrid vehicle applications. The company reported 14% YoY adjusted EBITDA growth to $115 million in Q2 with expanded margins of 36.6%, and raised its 2026 adjusted EBITDA guidance to $380-$400 million.Zacks Investment Research · Sep 8, 2026

Ingevity (NGVT) Q2 EPS Jumps 38%Ingevity reported Q2 2025 earnings with mixed results: non-GAAP EPS exceeded expectations at $1.39, but revenue declined 6.5% to $365.1 million. The company saw improved profitability and cash flow, with a significant goodwill impairment in Advanced Polymer Technologies.The Motley Fool · Aug 5, 2025

Ingevity's (NGVT) Earnings and Revenues Miss Estimates in Q2Ingevity Corporation reported a Q2 2024 loss of $283.7 million or $7.81 per share, down from a profit of $35.5 million a year ago. Revenues declined 18.9% year-over-year to $390.6 million, missing estimates. The company revised its sales and adjusted EBITDA guidance for 2024.Zacks Investment Research · Aug 5, 2024

Assessing Ingevity: Insights From 5 Financial Analysts - BenzingaThe article analyzes the recent ratings and price targets of 5 financial analysts for Ingevity, a chemical manufacturer. The analysts have a mixed outlook, with an average 12-month price target of $55.2 and a range of ratings from 'Outperform' to 'Underperform'. The company's financial performance, including declining revenue, low profitability, and high debt levels, are also discussed.Benzinga · Jul 11, 2024

Ingevity (NGVT), Ultrapolymers Tie-Up for Capa Bioplastics Sales - Zacks Investment ResearchIngevity Corporation has expanded its Capa caprolactone distribution network by selecting Ultrapolymers Group as the distributor for Capa Bioplastics in Europe. This move aligns with Ingevity's growth strategy in the region.Zacks Investment Research · Jul 11, 2024

Ingevity finalizes termination of key supply agreement By Investing.com - Investing.comIngevity Corp has finalized the termination of a significant crude tall oil supply agreement with GP Pine Chemicals, a subsidiary of Georgia-Pacific. The termination provides Ingevity more flexibility as it plans to restructure its Performance Chemicals business segment to focus on specialty chemicals markets.Investing.com · Jul 8, 2024

to start trading

NG

NGVTIngevity Corporation

NGVT

Pay with—

Available Balance0.00

Your PositionYou don't own any NGVT yet.

Related Tickers

Earnings